141 related articles for article (PubMed ID: 141906)
1. Mechanism of accumulation of the antitumor protein antibiotic neocarzinostatin in bladder tissue: intravenous administration, urinary excretion, and absorption into bladder tissue.
Maeda H; Sakamoto S; Ogata J
Antimicrob Agents Chemother; 1977 Jun; 11(6):941-5. PubMed ID: 141906
[TBL] [Abstract][Full Text] [Related]
2. Absorption, distribution and excretion of neocarzinostatin (NCS) in mice after oral administration.
Toriyama K; Fujita H; Ishida N
J Antibiot (Tokyo); 1975 Jan; 28(1):64-72. PubMed ID: 123896
[TBL] [Abstract][Full Text] [Related]
3. Clinical investigations of neocarzinostatin in Japan.
Kimura I
Recent Results Cancer Res; 1978; 63():252-60. PubMed ID: 151899
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effect of neocarzinostatin entrapped in liposomes.
Shinozawa S; Araki Y; Oda T
Gan; 1980 Feb; 71(1):107-11. PubMed ID: 6445846
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the protein antitumor antibiotic neocarzinostatin after bolus injection in humans.
Comis RL; Griffin TW; Raso V; Ginsberg SJ
Cancer Res; 1979 Mar; 39(3):757-61. PubMed ID: 154969
[No Abstract] [Full Text] [Related]
6. Efficacy of two-route chemotherapy using intraperitoneal neocarzinostatin and its antidote, intravenous tiopronin, for peritoneally disseminated tumors in mice.
Hasuda K; Kobayashi H; Kuroiwa T; Aoki K; Taniguchi S; Baba T
Jpn J Cancer Res; 1989 Mar; 80(3):283-9. PubMed ID: 2524462
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study of intralymphatic chemotherapy in rabbits].
Satomi A; Takada Y; Ishida K
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2262-8. PubMed ID: 2955746
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of the anticancer polypeptide neocarzinostatin.
Hall SW; Knight J; Broughton A; Benjamin RS; McKelvey E
Cancer Chemother Pharmacol; 1983; 10(3):200-4. PubMed ID: 6222845
[TBL] [Abstract][Full Text] [Related]
9. Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodies.
Gottschalk U; Garnett MC; Ward RK; Maibücher A; Köhnlein W
J Antibiot (Tokyo); 1991 Oct; 44(10):1148-54. PubMed ID: 1835456
[TBL] [Abstract][Full Text] [Related]
10. [Part I. Theory and computer simulation for cerebrospinal infusion].
Maeda H; Matsukado Y; Iwai Z; Uemura S; Kuratsu J; Takeshita J; Sano Y
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1040-5. PubMed ID: 6223592
[TBL] [Abstract][Full Text] [Related]
11. An uptake of fluorescein isothiocyanate labeled neocarzinostatin into the cancer and normal cells.
Sakamoto S; Maeda H; Ogata J
Experientia; 1979 Sep; 35(9):1233-5. PubMed ID: 158538
[TBL] [Abstract][Full Text] [Related]
12. Effects of systemic administration of neocarzinostatin, a new protein antibiotic, on human bladder cancer.
Sakamoto S; Ogata J; Ikegami K; Maeda H
Cancer Treat Rep; 1978 Mar; 62(3):453-4. PubMed ID: 148320
[No Abstract] [Full Text] [Related]
13. [Neocarzinostatin therapy of advanced renal cell carcinoma].
Tari K; Satake I; Kojima S; Tsujii T; Yonese J
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2719-23. PubMed ID: 2970825
[TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic simulation model for chemotherapy of brain tumor with an antitumor protein antibiotic, neocarzinostatin. Theoretical considerations behind a two-compartment model for continuous infusion via an internal carotid artery.
Maeda H; Sano Y; Takeshita J; Iwai Z; Kosaka H; Marubayashi T; Matsukado Y
Cancer Chemother Pharmacol; 1981; 5(4):243-9. PubMed ID: 6455212
[TBL] [Abstract][Full Text] [Related]
15. The promoting effect of amphotericin B on the incorporation of neocarzinostatin into human gastric cancer tissue.
Nakazawa I; Ouchi E; Ishida N; Takano S; Ouchi K; Wagai K
Tohoku J Exp Med; 1980 May; 131(1):101-2. PubMed ID: 6447386
[TBL] [Abstract][Full Text] [Related]
16. Lymphotropic accumulation of an antitumor antibiotic protein, neocarzinostatin.
Maeda H; Takeshita J; Yamashita A
Eur J Cancer (1965); 1980 May; 16(5):723-31. PubMed ID: 6446456
[No Abstract] [Full Text] [Related]
17. [Screening for antagonistic agents to the lethal toxicity of neocarzinostatin. II. Effects of various drugs in inhibiting the toxicity of neocarzinostatin in vivo].
Ouchi M; Toriyama K; Matsumoto T; Baba T
Jpn J Antibiot; 1988 Jan; 41(1):105-15. PubMed ID: 2966869
[TBL] [Abstract][Full Text] [Related]
18. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
Napier MA; Goldberg IH
Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
[TBL] [Abstract][Full Text] [Related]
19. In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS.
Takeshita J; Maeda H; Kanamaru R
Gan; 1982 Apr; 73(2):278-84. PubMed ID: 6214446
[TBL] [Abstract][Full Text] [Related]
20. Effect of amphotericin B on the incorporation of neocarzinostatin into human gastric cancerous tissues.
Nakazawa I; Ouchi E; Ishida N; Ouchi K; Wagai K
Tohoku J Exp Med; 1978 Jan; 124(1):97-8. PubMed ID: 147527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
